Literature DB >> 18219922

[A case of advanced gastric cancer with obstructive jaundice due to liver metastases successfully treated with chemotherapy].

Yasuhiro Miyazaki1, Hiroshi Imamura, Hiroshi Furukawa, Tomono Kishimoto, Katsuya Ohta, Yasuyuki Nakata, Ryouta Ohshiro, Shunji Kamigaki, Hiroyoshi Takemoto, Satoshi Fujimi, Takahiro Nakayama, Mutsumi Fukunaga, Hiroki Ohsata, Masayuki Tatsuta.   

Abstract

We report a successful case of chemotherapy for primary far-advanced gastric cancer accompanied with poor general condition related to jaundice due to hepatic metastasis. A 54-year-old man, who had been admitted to another hospital in October 2006 with a complaint of tarry stool, was referred to our hospital. The result of detailed examination revealed an advanced gastric cancer, multiple lymph node metastases and jaundice (T-Bil 3.3 mg/dL) due to multiple hepatic metastases. The performance status (PS) was level 4. In parallel with a whole body control, a combined therapy with S-1 and CPT-11 was performed from October 27 as the first-line therapy. As a consequence of the first course, the jaundice disappeared. After the second course, the patient left the hospital. However, the patient was re-admitted to hospital in January 2007 by a reason of fever and a deterioration of PS. As exacerbation of cancerous peritonitis and the primary tumor were seen, a weekly paclitaxel therapy was performed as the second-line therapy. Two courses of treatment resulted in the disappearance of ascites and a reduction of hepatic/lymph node metastasis. PS was improved to level 0 as well. After these therapies, the patient was discharged from the hospital. As of June 2007, he continuously receives chemotherapy as an outpatient.

Entities:  

Mesh:

Year:  2007        PMID: 18219922

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Protection of Salvia miltiorrhizae to the spleen and thymus of rats with severe acute pancreatitis or obstructive jaundice.

Authors:  Zhang Xiping; Li Chuyang; Zhang Jie; Ruan Yuefang; Ma Meili
Journal:  Mediators Inflamm       Date:  2009-11-16       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.